MLN518
Term · Oncology and biomedicine · MLC-T-ONC-005437
A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain enzymes. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called CT53518 and tandutinib.
| Identifier | MLC-T-ONC-005437 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | tandutinib |
| Synonyms | CT53518 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005437",
"term": "MLN518",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain enzymes. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called CT53518 and tandutinib.",
"expansions": [
"tandutinib"
],
"synonyms": [
"CT53518"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mln518/"
}
Record 11,141 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.